Altered hepatic lipid status and apolipoprotein A-I metabolism in mice lacking phospholipid transfer protein

Atherosclerosis

Volumn 190, Issue 1, 2007, Pages 114-123

  Siggins, Sarah ^a   Bykov, Igor ^a   Hermansson, Martin ^b   Somerharju, Pentti ^b   Lindros, Kai ^a   Miettinen, Tatu A ^c   Jauhiainen, Matti ^a   Olkkonen, Vesa M ^a   Ehnholm, Christian ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

ApoA I; Hepatocyte; Knockout mouse; Lipid metabolism; Lipoprotein; Liver; Phospholipid; Phospholipid transfer protein

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; CHOLINE; MONOUNSATURATED FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PHOSPHOLIPID TRANSFER PROTEIN; SPHINGOMYELIN; TRIACYLGLYCEROL; UNSATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; KNOCKOUT MOUSE; LIPID LIVER LEVEL; LIPOPROTEIN METABOLISM; LIVER CELL CULTURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN SECRETION; PROTEIN SYNTHESIS; WILD TYPE;

ANIMALS; APOLIPOPROTEIN A-I; CELLS, CULTURED; FEMALE; HEPATOCYTES; LIPOPROTEINS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHOLIPIDS; TRIGLYCERIDES;

EID: 33845537238     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.02.037     Document Type: Article

References (38)

1. Zanlungo S., Rigotti A., and Nervi F. Hepatic cholesterol transport from plasma into bile: implications for gallstone disease. Curr Opin Lipidol 15 (2004) 279-286
2. Fielding C.J., and Fielding P.E. Molecular physiology of reverse cholesterol transport. J Lipid Res 36 (1995) 211-228
3. Yokoyama S. Assembly of high density lipoprotein by the ABCA1/apolipoprotein pathway. Curr Opin Lipidol 16 (2005) 269-279
4. Wang N., Lan D., Chen W., Matsuura F., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 101 (2004) 9774-9779
5. Linsel-Nitschke P., and Tall A.R. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discovery 4 (2005) 193-205
6. Jauhiainen M., Metso J., Pahlman R., Blomqvist S., van Tol A., and Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 268 (1993) 4032-4036
7. Tu A.Y., Nishida H.I., and Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 268 (1993) 23098-23105
8. Oram J.F., Wolfbauer G., Vaughan A.M., Tang C., and Albers J.J. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. J Biol Chem 278 (2003) 52379-52385
9. Francone O.L., Subbaiah P.V., van Tol A., Royer L., and Haghpassand M. Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1. Biochemistry 42 (2003) 8569-8578
10. Jiang X.C., Bruce C., Mar J., et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 103 (1999) 907-914
11. Jiang X.C., Qin S., Qiao C., et al. B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med 7 (2001) 847-852
12. Kärkkäinen M., Oka T., Olkkonen V.M., et al. Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP). J Biol Chem 277 (2002) 15413-15418
13. Siggins S., Jauhiainen M., Olkkonen V.M., Tenhunen J., and Ehnholm C. PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma. J Lipid Res 44 (2003) 1698-1704
14. Barlage S., Frohlich D., Bottcher A., et al. ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res 42 (2001) 281-290
15. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226 (1957) 497-509
16. Smets F.N., Chen Y., Wang L.J., and Soriano H.E. Loss of cell anchorage triggers apoptosis (anoikis) in primary mouse hepatocytes. Mol Genet Metab 75 (2002) 344-352
17. van Haperen R., van Tol A., Vermeulen P., et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 20 (2000) 1082-1088
18. Käkelä R., Somerharju P., and Tyynelä J. Analysis of phospholipid molecular species in brains from patients with infantile and juvenile neuronal-ceroid lipofuscinosis using liquid chromatography-electrospray ionization mass spectrometry. J Neurochem 84 (2003) 1051-1065
19. Ahmad T.Y., Sparrow J.T., and Morrisett J.D. Fluorine-, pyrene-, and nitroxide-labeled sphingomyelin: semi-synthesis and thermotropic properties. J Lipid Res 26 (1985) 1160-1165
20. Hermansson M., Uphoff A., Käkelä R., and Somerharju P. Automated quantitative analysis of complex lipidomes by liquid chromatography/mass spectrometry. Anal Chem 77 (2005) 2166-2175
21. Ehnholm S., van Dijk K.W., van 't Hof B., van der Zee A., Olkkonen V.M., Jauhiainen M., et al. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J Lipid Res 39 (1998) 1248-1253
22. Albers J.J., Wolfbauer G., Cheung M.C., et al. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plama PLTP on HDL subspecies. Biochim Biophys Acta 1258 (1995) 27-34
23. Lie J.d.C.R., van Gent T., van Haperen R., Scheek L., Lankhuizen I., and van Tol A. Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. J Lipid Res 43 (2002) 1875-1880
24. Hasty A.H., Plummer M.R., Weisgraber K.H., Linton M.F., Fazio S., and Swift L.L. The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I. J Lipid Res 46 (2005) 1433-1439
25. Howell K.E., and Palade G.E. Heterogeneity of lipoprotein particles in hepatic Golgi fractions. J Cell Biol 92 (1982) 833-845
26. Banerjee D., and Redman C.M. Biosynthesis of high density lipoprotein by chicken liver: nature of nascent intracellular high density lipoprotein. J Cell Biol 96 (1983) 651-660
27. Qin S., Kawano K., Bruce C., et al. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. J Lipid Res 41 (2000) 269-276
28. Post S.M., de Crom R., van Haperen R., van Tol A., and Princen H.M. Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein. Arterioscler Thromb Vasc Biol 23 (2003) 892-897
29. Rye K.A., Clay M.A., and Barter P.J. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 145 (1999) 227-238
30. Hamilton R.L., Moorehouse A., and Havel R.J. Isolation and properties of nascent lipoproteins from highly purified rat hepatocytic Golgi fractions. J Lipid Res 32 (1991) 529-543
31. Chisholm J.W., Burleson E.R., Shelness G.S., and Parks J.S. ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL. J Lipid Res 43 (2002) 36-44
32. Zheng H., Kiss R.S., Franklin V., Wang M.D., Haidar B., and Marcel Y.L. ApoA-I lipidation in primary mouse hepatocytes. Separate controls for phospholipid and cholesterol transfers. J Biol Chem 280 (2005) 21612-21621
33. Kiss R.S., McManus D.C., Franklin V., et al. The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways. J Biol Chem 278 (2003) 10119-10127
34. Klon A.E., Segrest J.P., and Harvey S.C. Comparative models for human apolipoprotein A-I bound to lipid in discoidal high-density lipoprotein particles. Biochemistry 41 (2002) 10895-10905
35. Davidson W.S., Hazlett T., Mantulin W.W., and Jonas A. The role of apolipoprotein AI domains in lipid binding. Proc Natl Acad Sci USA 93 (1996) 13605-13610
36. Saito H., Dhanasekaran P., Nguyen D., Holvoet P., Lund-Katz S., and Phillips M.C. Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model. J Biol Chem 278 (2003) 23227-23232
37. Sparks D.L., Frank P.G., Braschi S., Neville T.A., and Marcel Y.L. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles. Biochemistry 38 (1999) 1727-1735
38. Brousseau M.E., Diffenderfer M.R., Millar J.S., et al. Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion. Arterioscler Thromb Vasc Biol 25 (2005) 1057-1064